Tocqueville Asset Management’s Iovance Biotherapeutics IOVA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-171,290
| Closed | -$2.85M | – | 688 |
|
|
2022
Q1 | $2.85M | Buy |
171,290
+30,350
| +22% | +$505K | 0.04% | 306 |
|
|
2021
Q4 | $2.69M | Sell |
140,940
-8,400
| -6% | -$160K | 0.04% | 343 |
|
|
2021
Q3 | $3.68M | Sell |
149,340
-12,750
| -8% | -$314K | 0.05% | 290 |
|
|
2021
Q2 | $4.22M | Buy |
162,090
+68,500
| +73% | +$1.78M | 0.06% | 280 |
|
|
2021
Q1 | $2.96M | Sell |
93,590
-1,860
| -2% | -$58.9K | 0.05% | 321 |
|
|
2020
Q4 | $4.43M | Buy |
95,450
+60,450
| +173% | +$2.8M | 0.07% | 247 |
|
|
2020
Q3 | $1.15M | Hold |
35,000
| – | – | 0.02% | 384 |
|
|
2020
Q2 | $961K | Hold |
35,000
| – | – | 0.02% | 396 |
|
|
2020
Q1 | $1.05M | Sell |
35,000
-25,000
| -42% | -$749K | 0.03% | 349 |
|
|
2019
Q4 | $1.66M | Sell |
60,000
-68,605
| -53% | -$1.9M | 0.02% | 377 |
|
|
2019
Q3 | $2.34M | Buy |
128,605
+1,550
| +1% | +$28.2K | 0.03% | 357 |
|
|
2019
Q2 | $3.12M | Buy |
127,055
+82,930
| +188% | +$2.03M | 0.04% | 347 |
|
|
2019
Q1 | $420K | Buy |
44,125
+17,300
| +64% | +$165K | 0.01% | 618 |
|
|
2018
Q4 | $237K | Buy |
26,825
+3,000
| +13% | +$26.5K | ﹤0.01% | 669 |
|
|
2018
Q3 | $268K | Sell |
23,825
-1,100
| -4% | -$12.4K | ﹤0.01% | 712 |
|
|
2018
Q2 | $319K | Buy |
24,925
+14,100
| +130% | +$180K | ﹤0.01% | 680 |
|
|
2018
Q1 | $183K | Buy |
+10,825
| New | +$183K | ﹤0.01% | 795 |
|
|
2017
Q2 | – | Sell |
-23,000
| Closed | -$171K | – | 814 |
|
|
2017
Q1 | $171K | Hold |
23,000
| – | – | ﹤0.01% | 767 |
|
|
2016
Q4 | $160K | Hold |
23,000
| – | – | ﹤0.01% | 769 |
|
|
2016
Q3 | $189K | Buy |
+23,000
| New | +$189K | ﹤0.01% | 784 |
|